Aln-Ttr, An Rnai Therapeutic For The Treatment Of Transthyretin (Ttr) Amyloidosis, Mediates Regression Of Peripheral Ttr Protein Deposits In A Transgenic Mouse Model
61St Annual Meeting of the American-Association-For-The-Study-Of-Liver-Diseases, Date: OCT 29-NOV 02, 2010, Location: Boston, MA, Sponsors: Amer Assoc Study Liver Dis
